SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-006754
Filing Date
2023-02-01
Accepted
2023-02-01 17:25:43
Documents
12
Period of Report
2023-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea172563-8k_immucell.htm   iXBRL 8-K 33713
  Complete submission text file 0001213900-23-006754.txt   204797

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE iccc-20230124.xsd EX-101.SCH 3227
3 XBRL LABEL FILE iccc-20230124_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE iccc-20230124_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT ea172563-8k_immucell_htm.xml XML 3482
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 23577917
SIC: 2835 In Vitro & In Vivo Diagnostic Substances